MTOR and chronic kidney disease: Clinical studies show reduced p-mTOR/mTOR in DKD (Xiong et al., 2019), while podocyte mTORC1 hyperactivation in obesity CKD exacerbates renal dysfunction (Iwata et al., 2020).